bioRxiv Science⌕ Search

bioRxiv · 10.1101/610782

Accurate Prediction of Genome-wide RNA Secondary Structure Profile Based On Extreme Gradient Boosting

Abstract

MotivationMany studies have shown that RNA secondary structure plays a vital role in fundamental cellular processes, such as protein synthesis, mRNA processing, mRNA assembly, ribosome function and eukaryotic spliceosomes. Identification of RNA secondary structure is a key step to understand the common mechanisms underlying the translation process. Recently, a few experimental methods were developed to measure genome-wide RNA secondary structure profile through high-throughput sequencing techniques, and have been successfully applied to genomes including yeast and human. However, these high-throughput methods usually have low precision and are hard to cover all nucleotides on the RNA due to limited sequencing coverage.\n\nResultsIn this study, we developed a new method for the prediction of genome-wide RNA secondary structure profile (TH-GRASP) from RNA sequence based on eXtreme Gradient Boosting (XGBoost). The method achieves an prediction with areas under the receiver operating characteristic curve (AUC) values greater than 0.9 on three different datasets, and AUC of 0.892 by an independent test on the recently released Zika virus RNA dataset. These AUCs represent a consistent increase of >6% than the recently developed method CROSS trained by a shallow neural network. A further analysis on the 1000-Genome Project data showed that our predicted unpaired probability at mutations sites are highly correlated with the minor allele frequencies (MAF) of synonymous, non-synonymous mutations, and mutations in 3 and 5UTR with Pearson Correlation Coefficients all above 0.8. These PCCs are consistently higher than those generated by RNAplfold method. Moreover, an investigation over all human mRNA indicated a periodic distribution of the predicted unpaired probability on codons, and a decrease of paired probability in the boundary with 5 and 3 untranslated regions. These results highlighted TH-GRASP is effective to remove experimental noises and to have ability to make predictions on nucleotides with low or no coverage by fitting high-throughput genomic data for RNA secondary structure profiles, and also suggested that building model on high throughput experimental data might be a future direction to substitute analytical methods.\n\nAvailabilityThe TH-GRASP is available for academic use at https://github.com/sysu-yanglab/TH-GRASP.\n\nSupplementary informationSupplementary data are available online.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ke, Y., Rao, J., Zhao, H., Lu, Y., Xiao, N., Yang, Y.. 2019-04-16. Accurate Prediction of Genome-wide RNA Secondary Structure Profile Based On Extreme Gradient Boosting. https://doi.org/10.1101/610782

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Classifying tumors from broad category to hierarchical molecular subtype: an interpretable hierarchical framework for precision oncology

Precise tumor subtype classification is important for guiding personalized treatment, characterizing tumor heterogeneity, and investigating molecular mechanisms. However, most existing multi-label classification models use flat architectures and do not fully exploit the inherent hierarchical relationships and biological constraints among tumor types, which limits their performance and interpretability in complex, fine-grained pan-cancer classification. Here, we present the cancer Hallmark-based Hierarchical Recursive Model (HHRM) for pan-cancer hierarchical multi-label classification. HHRM integrates hierarchical label structures with recursive neural networks, enabling simultaneous modeling of multi-level dependencies from broad cancer categories to specific subtypes. We trained the model on a comprehensive pan-cancer cohort of 11,476 samples spanning 26 primary cancer types and 405 subtypes across up to eight hierarchical levels. HHRM achieved an accuracy of 0.7924 for predicting hierarchical tumor subtypes and was further evaluated on a validation dataset of 887 samples. Compared with other hierarchical modeling frameworks, HHRM achieved higher accuracy in all three output modes. Ablation experiments showed that replacing the hallmark-based graph convolutional network reduced model performance. On an independent dataset of 1,608 breast cancer samples, HHRM also achieved an accuracy greater than 0.86. Finally, we combined SHAP with a network-based method to rank and analyze predictive genes at different levels of the tumor hierarchy, which identified both known and potentially novel biomarkers for cancer diagnosis. In conclusion, to our knowledge, HHRM is the first hierarchical model for multi-level tumor subtype classification. Its competitive performance, combined with post hoc biological interpretation, suggests potential value for precision cancer diagnosis.

bioinformatics↗

A comparative transcriptomic framework across kidney organoid, assembloid, and transplantation models

Human kidney organoids recapitulate key aspects of renal development and have emerged as valuable platforms for disease modeling, nephrotoxicity screening, and therapeutic development. The field now includes a wide range of emerging protocols with distinct cellular compositions and maturation states, which complicates systematic comparison and model selection. Here, we integrated single-cell and single-nucleus transcriptomes from 11 studies spanning kidney organoid and assembloids, both in vitro and following transplantation, benchmarked against fetal and adult kidney references. Transcriptional maturation toward adult identity is compartment specific and does not correlate with protocol complexity. Assembloid protocols show the most adult-like podocyte and distal nephron signatures, transplantation is associated with enhanced tubular oxidative metabolic features, only protocols incorporating ureteric progenitors reliably generate collecting-duct lineages, and no protocol achieves mature adult proximal tubule identity. Annotating against either fetal or adult kidney reference alone leads to misassignment, because early fetal nephron epithelium transcriptionally resembles injury-dedifferentiated adult proximal tubule cells. Assembloid and transplantation models share elevated mechanosensing pathway expression independently of vascularization. Together, these findings provide a framework for kidney organoid model selection.

bioinformatics↗

OncoSpot enables benchmarking of cancer spatial transcriptomics methods across tumor evolutionary modes

Spatial transcriptomics (ST) is increasingly used to map clonal architecture within tumors, yet methods for analyzing cancer ST data are difficult to evaluate because real tumors lack ground truth for copy-number alterations (CNAs), subclonal identity, and malignant cell fraction. Existing ST simulators model normal tissue and do not represent tumor evolution, CNA-driven expression, or the spatial organization of malignant subclones. We present OncoSpot, a cancer-aware simulator of Visium-like spot-based ST data. OncoSpot combines a spatial evolutionary scaffold from DEMON, CNAs generated along the resulting clonal phylogeny with CNAsim, cancer-type-specific malignant transcriptional programs, and spatially clustered nonmalignant cell types, and aggregates cells into spots with known malignant fraction, subclone, and copy-number profiles. We demonstrate OncoSpot on high-grade serous ovarian carcinoma, colorectal cancer, and hepatocellular carcinoma, which represent three distinct modes of tumor evolution. Simulated subclones were spatially clustered and showed stronger phylogeny-space concordance than those generated by scCube under matched subclone populations. Benchmarking CopyKAT, CancerFinder, Clonalscope, and RCTD revealed cancer-dependent performance: Clonalscope recovered copy-number signals more accurately in ovarian and colorectal cancer, whereas CopyKAT performed better in hepatocellular carcinoma, reflecting both the assumptions of each method and the copy-number landscapes of the three cancers. OncoSpot's ground truth also exposed a failure mode in Clonalscope's malignant spot identification, in which tumor and normal labels were inverted, and allowed us to trace its cause. These method-dependent behaviors would be difficult to detect in real data. OncoSpot provides a framework for benchmarking CNA inference, subclone detection, malignant spot identification, and normal spot deconvolution, and its modular design and guidelines allow extension to additional cancer types. OncoSpot is freely available at https://github.com/compbio-mallory/OncoSpot.

bioinformatics↗